PetVivo Holdings (PETV) Return on Sales [ROS] (2015 - 2026)
PetVivo Holdings (PETV) reported Return on Sales [ROS] of -476.59% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 143.34 percentage points from -619.94% a year earlier and up 686.20 percentage points from the prior quarter.
PetVivo Holdings (PETV) Return on Sales [ROS] (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, PetVivo Holdings' Return on Sales [ROS] came in at -747.03%, down 145.66 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at -793.88%, down 82.58 percentage points from FY2025.
- Return on Sales [ROS] has a five-year change of +14780.84 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Sales [ROS] came in at -711.30% in FY2025 (+385.15 pp), -1096.45% in FY2024 (-144.22 pp), -952.23% in FY2023 (+3422.46 pp) and -4374.69% in FY2022 (+11200.03 pp).
- The fiscal Q1 2027 figure ranks as the highest quarterly Return on Sales [ROS] since fiscal Q3 2025.
- Year over year, Return on Sales [ROS] gained in six of the last eight quarters, with an average year-over-year change of +729.20 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was fiscal Q3 2022 (a gain of 72763.77 percentage points); the low point was fiscal Q2 2022 (a drop of 5080.02 percentage points).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -1162.80% (Q4 2026), -765.95% (Q3 2026) and -681.00% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | PetVivo Holdings | 28.46 Mn | 27.20 Mn | 223,317.00 | -476.59% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -476.59% |
| Mar 31, 2026 | -1,162.80% |
| Dec 31, 2025 | -765.95% |
| Sep 30, 2025 | -681.00% |
| Jun 30, 2025 | -619.94% |
| Mar 31, 2025 | -925.40% |
| Dec 31, 2024 | -301.45% |
| Sep 30, 2024 | -1,082.62% |
| Jun 30, 2024 | -1,652.05% |
| Mar 31, 2024 | -5,489.98% |
| Dec 31, 2023 | -358.06% |
| Sep 30, 2023 | -1,419.88% |
| Jun 30, 2023 | -2,469.28% |
| Mar 31, 2023 | -1,854.29% |
| Dec 31, 2022 | -454.57% |
| Sep 30, 2022 | -949.29% |
| Jun 30, 2022 | -3,379.68% |
| Mar 31, 2022 | -3,204.11% |
| Dec 31, 2021 | -3,250.04% |
| Sep 30, 2021 | -22,169.10% |
PetVivo Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PETV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "PETV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PETV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();